<akomaNtoso xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://docs.oasis-open.org/legaldocml/ns/akn/3.0 http://docs.oasis-open.org/legaldocml/akn-core/v1.0/os/part2-specs/schemas/akomantoso30.xsd" xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0" xmlns:html="http://www.w3.org/1999/xhtml" xmlns:akn4un="http://un.org/akn4un">
  <!--This is an unofficial copy for informational purposes only and prepared from the official electronic file-->
  <statement name="resolution">
    <meta>
      <identification source="#DGACM">
        <FRBRWork>
          <FRBRthis value="/akn/un/statement/deliberation/unga/2024-12-17/79-191/!main/"></FRBRthis>
          <FRBRuri value="/akn/un/statement/deliberation/unga/2024-12-17/79-191/"></FRBRuri>
          <FRBRdate date="2024-12-17" name="adoption"></FRBRdate>
          <FRBRauthor href="ga" as="author"></FRBRauthor>
          <FRBRcountry value="un"></FRBRcountry>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/akn/un/statement/deliberation/unga/2024-12-17/79-191/eng@!main/"></FRBRthis>
          <FRBRuri value="/akn/un/statement/deliberation/unga/2024-12-17/79-191/eng@/"></FRBRuri>
          <FRBRdate date="2024-12-18" name="publication"></FRBRdate>
          <FRBRauthor href="ga" as="issuer"></FRBRauthor>
          <FRBRlanguage language="eng"></FRBRlanguage>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/akn/un/statement/deliberation/unga/2024-12-17/79-191/eng@/!main.xml"></FRBRthis>
          <FRBRuri value="/akn/un/statement/deliberation/unga/2024-12-17/79-191/eng@.xml"></FRBRuri>
          <FRBRdate date="2025-01-24" name="markup"></FRBRdate>
          <FRBRauthor href="DGACM" as="editor"></FRBRauthor>
        </FRBRManifestation>
      </identification>
      <classification source="https://metadata.un.org/sdg">
        <keyword value="3" href="http://metadata.un.org/sdg/3" showAs="sdg_3" dictionary="SDGO"/>
        <keyword value="public_health" href="http://eurovoc.europa.eu/3885" showAs="public_health" dictionary="EuroVoc"/>
        <keyword value="public_health" href="http://metadata.un.org/thesaurus/1005250" showAs="public_health" dictionary="UNBIS"/>
        <keyword value="health" href="http://metadata.un.org/thesaurus/1002824" showAs="health" dictionary="UNBIS"/>
      </classification>
      <classification source="https://metadata.un.org/sdg">
        <keyword value="16" href="http://metadata.un.org/sdg/16" showAs="sdg_16" dictionary="SDGO"/>
        <keyword value="sustainable_development" href="http://eurovoc.europa.eu/5585" showAs="sustainable_development" dictionary="EuroVoc"/>
        <keyword value="sustainable_development" href="http://metadata.un.org/thesaurus/1006319" showAs="sustainable_development" dictionary="UNBIS"/>
        <keyword value="justice" href="http://metadata.un.org/thesaurus/1003500" showAs="justice" dictionary="UNBIS"/>
        <keyword value="civil_society" href="http://eurovoc.europa.eu/8428" showAs="civil_society" dictionary="EuroVoc"/>
        <keyword value="civil_society" href="http://metadata.un.org/thesaurus/1001012" showAs="civil_society" dictionary="UNBIS"/>
        <keyword value="peaceful_coexistence" href="http://metadata.un.org/thesaurus/1004777" showAs="peaceful_coexistence" dictionary="UNBIS"/>
        <keyword value="social_justice" href="http://metadata.un.org/thesaurus/1005970" showAs="social_justice" dictionary="UNBIS"/>
        <keyword value="right_to_justice" href="http://eurovoc.europa.eu/516" showAs="right_to_justice" dictionary="EuroVoc"/>
        <keyword value="public_institution" href="http://eurovoc.europa.eu/878" showAs="public_institution" dictionary="EuroVoc"/>
        <keyword value="public_institution" href="http://metadata.un.org/thesaurus/1005254" showAs="public_institution" dictionary="UNBIS"/>
      </classification>
      <classification source="https://metadata.un.org/sdg">
        <keyword value="5" href="http://metadata.un.org/sdg/5" showAs="sdg_5" dictionary="SDGO"/>
        <keyword value="gender_equality" href="http://eurovoc.europa.eu/3913" showAs="gender_equality" dictionary="EuroVoc"/>
        <keyword value="gender_equality" href="http://metadata.un.org/thesaurus/1002612" showAs="gender_equality" dictionary="UNBIS"/>
        <keyword value="women" href="http://metadata.un.org/thesaurus/1007029" showAs="women" dictionary="UNBIS"/>
        <keyword value="participation_of_women" href="http://eurovoc.europa.eu/2265" showAs="participation_of_women" dictionary="EuroVoc"/>
        <keyword value="girls" href="http://metadata.un.org/thesaurus/1002684" showAs="girls" dictionary="UNBIS"/>
        <keyword value="women's_rights" href="http://eurovoc.europa.eu/585" showAs="women's_rights" dictionary="EuroVoc"/>
        <keyword value="women's_rights" href="http://metadata.un.org/thesaurus/1007035" showAs="women's_rights" dictionary="UNBIS"/>
        <keyword value="position_of_women" href="http://eurovoc.europa.eu/81" showAs="position_of_women" dictionary="EuroVoc"/>
      </classification>
      <classification source="https://metadata.un.org/sdg">
        <keyword value="2" href="http://metadata.un.org/sdg/2" showAs="sdg_2" dictionary="SDGO"/>
        <keyword value="food_security" href="http://eurovoc.europa.eu/c_4523e1dd" showAs="food_security" dictionary="EuroVoc"/>
        <keyword value="food_security" href="http://metadata.un.org/thesaurus/1002439" showAs="food_security" dictionary="UNBIS"/>
        <keyword value="sustainable_agriculture" href="http://eurovoc.europa.eu/6308" showAs="sustainable_agriculture" dictionary="EuroVoc"/>
        <keyword value="sustainable_agriculture" href="http://metadata.un.org/thesaurus/1006317" showAs="sustainable_agriculture" dictionary="UNBIS"/>
        <keyword value="food_shortage" href="http://eurovoc.europa.eu/2318" showAs="food_shortage" dictionary="EuroVoc"/>
        <keyword value="food_shortage" href="http://metadata.un.org/thesaurus/1002440" showAs="food_shortage" dictionary="UNBIS"/>
        <keyword value="hunger" href="http://eurovoc.europa.eu/961" showAs="hunger" dictionary="EuroVoc"/>
        <keyword value="hunger" href="http://metadata.un.org/thesaurus/1003004" showAs="hunger" dictionary="UNBIS"/>
      </classification>
      <classification source="https://metadata.un.org/sdg">
        <keyword value="11" href="http://metadata.un.org/sdg/11" showAs="sdg_11" dictionary="SDGO"/>
        <keyword value="cities" href="http://metadata.un.org/thesaurus/1000995" showAs="cities" dictionary="UNBIS"/>
        <keyword value="human_settlements" href="http://metadata.un.org/thesaurus/1002986" showAs="human_settlements" dictionary="UNBIS"/>
        <keyword value="urban_area" href="http://eurovoc.europa.eu/4809" showAs="urban_area" dictionary="EuroVoc"/>
        <keyword value="urban_area" href="http://metadata.un.org/thesaurus/1006809" showAs="urban_area" dictionary="UNBIS"/>
      </classification>
      <classification source="DHLAUTH">
        <keyword value="UN Office on Drugs and Crime" showAs="UN Office on Drugs and Crime" dictionary="DHLAUTH"></keyword>
        <keyword value="UN. Commission on Narcotic Drugs" showAs="UN. Commission on Narcotic Drugs" dictionary="DHLAUTH"></keyword>
        <keyword value="WHO" showAs="WHO" dictionary="DHLAUTH"></keyword>
        <keyword value="DRUG CONTROL" href="http://metadata.un.org/thesaurus/1001775" showAs="DRUG CONTROL" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="NARCOTIC DRUGS" href="http://metadata.un.org/thesaurus/1004312" showAs="NARCOTIC DRUGS" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="DRUG POLICY" href="http://metadata.un.org/thesaurus/1001779" showAs="DRUG POLICY" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="DRUG TRAFFIC" href="http://metadata.un.org/thesaurus/1001786" showAs="DRUG TRAFFIC" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="INTERNATIONAL COOPERATION" href="http://metadata.un.org/thesaurus/1003291" showAs="INTERNATIONAL COOPERATION" dictionary="UNBIS Thesaurus"></keyword>
        <keyword refersTo="agenda" value="109" showAs="International drug control." shortForm="NARCOTIC DRUGS" dictionary="A/79/251"></keyword>
      </classification>
      <workflow source="#un">
        <step date="2024-11-13" outcome="draftResolution" as="A/C.3/79/L.6/Rev.1" by="Albania, Bosnia and Herzegovina, Guatemala, Honduras, Japan, Liberia, Mexico and South Africa" />
        <step date="0001-01-01" outcome="draftResolutionAdditionalSponsors" by="Andorra, Antigua and Barbuda, Australia, Austria, Belgium, Bolivia (Plurinational State of), Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, CÃ´te d'Ivoire, Croatia, Cyprus, Czechia, Denmark, Dominican Republic, El Salvador, Equatorial Guinea, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Jamaica, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Monaco, Montenegro, Morocco, Netherlands (Kingdom of the), New Zealand, Norway, Panama, Paraguay, Philippines, Poland, Portugal, Republic of Korea, Republic of Moldova, Romania, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Thailand, Trinidad and Tobago, United Kingdom and United States" />
        <step date="2024-11-27" outcome="recommendedForAdoption" as="A/79/461" by="" refersTo="11" />
        <step date="2024-12-17" outcome="adopted" as="A/79/PV.53" by="" />
      </workflow>
      <analysis source="#un">
        <parliamentary>
          <voting outcome="adoptedWithoutVote">
            <quorum value=""></quorum>
          </voting>
        </parliamentary>
      </analysis>
      <references source="#DGACM">
        <TLCOrganization eId="source" href="/akn/ontology/organization/un/DGACM" showAs="DGACM"></TLCOrganization>
        <TLCConcept eId="dateOfIssuance" href="/akn/ontology/concept/un/dateOfIssuance" showAs="Date of issuance"></TLCConcept>
        <TLCConcept eId="dateOfAdoption" href="/akn/ontology/concept/un/dateOfAdoption" showAs="Date of adoption"></TLCConcept>
        <TLCConcept eId="symbol" href="/akn/ontology/reference/un/symbol" showAs="Symbol"></TLCConcept>
        <TLCRole eId="publisher" href="/akn/ontology/role/un/publisher" showAs="Publisher"></TLCRole>
        <TLCRole eId="issuingBody" href="/akn/role/concept/un/issuingBody" showAs="Issuing body"></TLCRole>
        <TLCRole eId="author" href="/akn/ontology/role/un/author" showAs="Author"></TLCRole>
        <TLCRole eId="editor" href="/akn/ontology/role/un/editor" showAs="Editor"></TLCRole>
        <TLCRole eId="distribution" href="/akn/ontology/concept/un/generalDistribution" showAs="General distribution"></TLCRole>
        <TLCOrganization eId="ga" href="/akn/ontology/organization/un/generalAssembly" showAs="General Assembly"></TLCOrganization>
        <TLCTerm eId="resolutionTitle" href="/akn/ontology/reference/un/resolutionTitle" showAs="Resolution title"></TLCTerm>
        <TLCTerm eId="thirdCommittee" href="#thirdCommittee" showAs="Third Committee"></TLCTerm>
        <TLCTerm eId="memberState" href="/akn/ontology/organization/un/memberState" showAs="Member State"></TLCTerm>
        <TLCTerm eId="inFavour" href="/akn/ontology/concept/un/voting/inFavour" showAs="In favour"></TLCTerm>
        <TLCTerm eId="against" href="/akn/ontology/concept/un/voting/against" showAs="Against"></TLCTerm>
        <TLCTerm eId="abstaining" href="/akn/ontology/concept/un/voting/abstaining" showAs="Abstaining"></TLCTerm>
      </references>
      <presentation source="#un">
        <akn4un:footerFirstPage>
          <akn4un:footerFirstPageLeft>
            <akn4un:internalCode>
              <docketNumber refersTo="#publicationJobNumber">24-24134 (E)</docketNumber>
              <img alt="bar code" class="barCode" src=""></img>
            </akn4un:internalCode>
          </akn4un:footerFirstPageLeft>
          <akn4un:footerFirstPageRight>
            <img alt="Please recycle" class="image" src="./recylcleLogo.jpg"></img>
            <img alt="embedded QR code" class="qrCode" src=""></img>
          </akn4un:footerFirstPageRight>
        </akn4un:footerFirstPage>
      </presentation>
    </meta>
    <coverPage eId="coverPage_1">
      <p>
        <span refersTo="#publisher" class="upperLeft">
          <docAuthority refersTo="#publisher">United Nations</docAuthority>
        </span>
      </p>
      <p class="upperRight">
        <docNumber refersTo="#symbol">A/RES/79/191</docNumber>
      </p>
      <p class="upperLeft">
        <img src="logo-un.jpg"></img>
        <docAuthority refersTo="#issuingBody" class="rightBig">General Assembly</docAuthority>
      </p>
      <p>
        <docStatus refersTo="#generalDistribution" class="rightSmall">Distr.: General</docStatus>
      </p>
      <p>
        <docDate date="2024-12-18" class="rightSmall" refersTo="#dateOfIssuance">18 December 2024</docDate>
      </p>
      <p>
        <session refersTo="#generalAssembly" value="79" eId="coverPage_1__session_1">Seventy-ninth session</session>
      </p>
      <p>
        <inline title="109" name="agenda item">Agenda item 109</inline>
      </p>
      <p>
        <inline name="agenda item name">International drug control</inline>
      </p>
      <p>
        <docTitle>Resolution adopted by the General Assembly on 17 December 2024</docTitle>
      </p>
      <p xml:space="preserve">
        <docProponent refersTo="#thirdCommittee">[on the report of the Third Committee (<inline name="originating document">A/79/461, para. 11</inline>)]</docProponent>
      </p>
    </coverPage>
    <preface>
      <p>
        <docNumber>79/191.</docNumber>
        <docTitle refersTo="#resolutionTitle">
          <span class="bold">	Addressing and countering the world drug problem through a comprehensive, integrated and balanced approach</span>
        </docTitle>
      </p>
    </preface>
    <preamble>
      <formula name="enactingFormula" eId="formula_1">
        <p xml:space="preserve">
          <span class="italic">The General Assembly</span>,</p>
      </formula>
      <container name="Underscoring" eId="container_2">
        <p xml:space="preserve">	<span class="italic">Underscoring</span> that the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol,<authorialNote marker="1" placement="bottom" eId="authorialNote_1"><p xml:space="preserve">		United Nations, <span class="italic">Treaty Series</span>, vol. 976, No. 14152.</p></authorialNote> the Convention on Psychotropic Substances of 1971,<authorialNote marker="2" placement="bottom" eId="authorialNote_2"><p xml:space="preserve">		Ibid., vol. 1019, No. 14956.</p></authorialNote> the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988<authorialNote marker="3" placement="bottom" eId="authorialNote_3"><p xml:space="preserve">		Ibid., vol. 1582, No. 27627.</p></authorialNote> and other relevant international instruments constitute the cornerstone of the international drug control system,</p>
      </container>
      <container name="Reaffirming its commitment" eId="container_3">
        <p xml:space="preserve">
          <span class="italic">	Reaffirming its commitment</span> to the goals and objectives of the three international drug control conventions, including concern about the health and welfare of humankind as well as the individual and public health-related, social and safety problems resulting from the abuse of narcotic drugs and psychotropic substances, in particular among children and young people, and drug-related crime, and reaffirming its determination to prevent and treat the abuse of such substances and prevent and counter their illicit cultivation, production, manufacturing and trafficking,</p>
      </container>
      <container name="Reaffirming" eId="container_4">
        <p xml:space="preserve">
          <span class="italic">	Reaffirming </span>the 2009 Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem,<authorialNote marker="4" placement="bottom" eId="authorialNote_4"><p xml:space="preserve">		See <span class="italic">Official Records of the Economic and Social Council, 2009, Supplement No. 8</span> (<a href="https://undocs.org/en/E/2009/28">E/2009/28</a>), chap. I, sect. C.</p></authorialNote> the Joint Ministerial Statement of the 2014 high-level review by the Commission on Narcotic Drugs of the implementation by Member States of the Political Declaration and Plan of Action<authorialNote marker="5" placement="bottom" eId="authorialNote_5"><p xml:space="preserve">		Ibid., <span class="italic">2014, Supplement No. 8</span> (<a href="https://undocs.org/en/E/2014/28">E/2014/28</a>), chap. I, sect. C.</p></authorialNote> and the outcome document of the thirtieth special session of the General Assembly, held in 2016,<authorialNote marker="6" placement="bottom" eId="authorialNote_6"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/S-30/1">S-30/1</a>, annex.</p></authorialNote> and reaffirming also the 2019 Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem,<authorialNote marker="7" placement="bottom" eId="authorialNote_7"><p xml:space="preserve">		See <span class="italic">Official Records of the Economic and Social Council, 2019, Supplement No. 8</span> (<a href="https://undocs.org/en/E/2019/28">E/2019/28</a>), chap. I, sect. B.</p></authorialNote> as well as the high-level declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the Ministerial Declaration of 2019,<authorialNote marker="8" placement="bottom" eId="authorialNote_8"><p xml:space="preserve">		Ibid., <span class="italic">2024, Supplement No. 8</span> (<a href="https://undocs.org/en/E/2024/28">E/2024/28</a>), chap. I, sect. B.</p></authorialNote></p>
      </container>
      <container name="Reaffirming also" eId="container_5">
        <p xml:space="preserve">	<span class="italic">Reaffirming also</span> the Universal Declaration of Human Rights,<authorialNote marker="9" placement="bottom" eId="authorialNote_9"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/217(III)">217 A (III)</a>.</p></authorialNote> and recalling the International Covenant on Economic, Social and Cultural Rights,<authorialNote marker="10" placement="bottom" eId="authorialNote_10"><p xml:space="preserve">		See resolution <a href="https://undocs.org/en/A/RES/2200(XXI)">2200 A (XXI)</a>, annex.</p></authorialNote> the International Covenant on Civil and Political Rights,<authorialNote marker="11" placement="bottom" eId="authorialNote_11"><p xml:space="preserve">		Ibid. </p></authorialNote> the Vienna Declaration and Programme of Action<authorialNote marker="12" placement="bottom" eId="authorialNote_12"><p xml:space="preserve">		<a href="https://undocs.org/en/A/CONF.157/24(PartI)">A/CONF.157/24 (Part I)</a>, chap. III.</p></authorialNote> and other relevant international human rights instruments,</p>
      </container>
      <container name="Recalling" eId="container_6">
        <p xml:space="preserve">
          <span class="italic">	Recalling </span>the commitments made by States parties to the Convention on the Rights of the Child,<authorialNote marker="13" placement="bottom" eId="authorialNote_13"><p xml:space="preserve">		United Nations, <span class="italic">Treaty Series</span>, vol. 1577, No. 27531.</p></authorialNote> including in article 33, which states that States parties should take all appropriate measures, including legislative, administrative, social and educational measures, to protect children from the illicit use of narcotic drugs and psychotropic substances as defined in the relevant international treaties, and to prevent the use of children in the illicit production and trafficking of such substances,</p>
      </container>
      <container name="Recalling also" eId="container_7">
        <p xml:space="preserve">	<span class="italic">Recalling also</span> all relevant United Nations resolutions, including General Assembly resolutions related to addressing and countering the world drug problem and all resolutions and decisions adopted by the Commission on Narcotic Drugs,</p>
      </container>
      <container name="Reaffirming its unwavering commitment" eId="container_8">
        <p xml:space="preserve">	<span class="italic">Reaffirming its unwavering commitment</span> to ensuring that all aspects of demand reduction and related measures, supply reduction and related measures, and international cooperation are addressed in full conformity with the purposes and principles of the Charter of the United Nations, international law and the Universal Declaration of Human Rights, with full respect for the sovereignty and territorial integrity of States, the principle of nonâintervention in the internal affairs of States, all human rights, fundamental freedoms, the inherent dignity of all individuals and the principles of equal rights and mutual respect among States, </p>
      </container>
      <container name="Reaffirming" eId="container_9">
        <p xml:space="preserve">	<span class="italic">Reaffirming</span> the 2030 Agenda for Sustainable Development,<authorialNote marker="14" placement="bottom" eId="authorialNote_14"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/70/1">70/1</a>.</p></authorialNote> and noting that efforts to achieve the Sustainable Development Goals and to effectively address the world drug problem should be complementary and mutually reinforcing,</p>
      </container>
      <container name="Reaffirming also" eId="container_10">
        <p xml:space="preserve">	<span class="italic">Reaffirming also </span>the principal role of the Commission on Narcotic Drugs as the policymaking body of the United Nations system with prime responsibility for drug control and other drug-related matters, as well as the treaty-mandated functions of the Commission to consider and make recommendations relating to all matters pertaining to the aims and provisions of the United Nations drug conventions, reaffirming also the support and appreciation of the General Assembly for the efforts of the United Nations, in particular those of the United Nations Office on Drugs and Crime as the leading entity in the United Nations system for addressing and countering the world drug problem, and reaffirming further the treaty-mandated roles of the International Narcotics Control Board and the World Health Organization, </p>
      </container>
      <container name="Recognizing" eId="container_11">
        <p xml:space="preserve">
          <span class="italic">	Recognizing</span> the role and contributions of the United Nations Development Programme, the Office of the United Nations High Commissioner for Human Rights, the Joint United Nations Programme on HIV/AIDS, the United Nations Entity for Gender Equality and the Empowerment of Women (UN-Women), the United Nations Educational, Scientific and Cultural Organization, the International Maritime Organization and the Universal Postal Union, as well as other international organizations, including the International Criminal Police Organization (INTERPOL) and the World Customs Organization, within their respective mandates, </p>
      </container>
      <container name="Taking note" eId="container_12">
        <p xml:space="preserve">
          <span class="italic">	Taking note </span>of Human Rights Council resolution <a href="https://undocs.org/en/A/hrc/RES/52/24">52/24</a> of 4Â April 2023, entitled âContribution of the Human Rights Council with regard to the human rights implications of drug policyâ,<authorialNote marker="15" placement="bottom" eId="authorialNote_15"><p xml:space="preserve">		See <span class="italic">Official Records of the General Assembly, Seventy-eighth Session, Supplement No. 53</span> (<a href="https://undocs.org/en/A/78/53">A/78/53</a>), chap. V, sect. A.</p></authorialNote> as well as of the recent reports on drugs by the Office of the United Nations High Commissioner for Human Rights<authorialNote marker="16" placement="bottom" eId="authorialNote_16"><p xml:space="preserve">		<a href="https://undocs.org/en/A/HRC/54/53">A/HRC/54/53</a>.</p></authorialNote> and the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health,<authorialNote marker="17" placement="bottom" eId="authorialNote_17"><p xml:space="preserve">		<a href="https://undocs.org/en/A/79/177">A/79/177</a> and <a href="https://undocs.org/en/A/HRC/56/52">A/HRC/56/52</a>.</p></authorialNote> </p>
      </container>
      <container name="Taking note also" eId="container_13">
        <p xml:space="preserve">	<span class="italic">Taking note also </span>of the <span class="italic">World Drug Report 2023</span> and the <span class="italic">World Drug Report 2024</span>, as well as of the reports of the International Narcotics Control Board for 2022 and 2023 and the supplementary reports thereto,</p>
      </container>
      <container name="Recognizing" eId="container_14">
        <p xml:space="preserve">
          <span class="italic">	Recognizing</span> that the three international drug control conventions concern the health and welfare of humankind and that human rights are an indispensable part of the international legal framework for the design and implementation of drug policies, and bearing in mind efforts to address the human rights consequences of the world drug problem,</p>
      </container>
      <container name="Noting with appreciation" eId="container_15">
        <p xml:space="preserve">	<span class="italic">Noting with appreciation</span> the contributions of United Nations entities, international financial institutions and relevant regional and international organizations, within their respective mandates, to the work of the Commission on Narcotic Drugs and the efforts of Member States to address and counter the world drug problem, upon their request, and to strengthen international and inter-agency cooperation, and encouraging them to make available relevant information to the Commission, including during its future thematic discussions, in order to facilitate its work and to enhance coherence within the United Nations system at all levels with regard to the world drug problem, </p>
      </container>
      <container name="Recalling" eId="container_16">
        <p xml:space="preserve">	<span class="italic">Recalling</span> relevant United Nations standards and norms in crime prevention and criminal justice, including the United Nations Rules for the Treatment of Women Prisoners and Non-custodial Measures for Women Offenders (the Bangkok Rules),<authorialNote marker="18" placement="bottom" eId="authorialNote_18"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/65/229">65/229</a>, annex.</p></authorialNote> the United Nations Standard Minimum Rules for Non-custodial Measures (the Tokyo Rules)<authorialNote marker="19" placement="bottom" eId="authorialNote_19"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/45/110">45/110</a>, annex.</p></authorialNote> and the United Nations Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules),<authorialNote marker="20" placement="bottom" eId="authorialNote_20"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/70/175">70/175</a>, annex.</p></authorialNote> </p>
      </container>
      <container name="Recalling also" eId="container_17">
        <p xml:space="preserve">
          <span class="italic">	Recalling also </span>the need to develop, adopt and implement, with due regard for national, constitutional, legal and administrative systems, alternative or additional measures with regard to conviction or punishment in cases of an appropriate nature, in accordance with the three international drug control conventions and taking into account, as appropriate, relevant United Nations standards and rules,</p>
      </container>
      <container name="Condemning" eId="container_18">
        <p xml:space="preserve">	<span class="italic">Condemning</span> any discriminatory or violent practice perpetrated by law enforcement officials against drug users, as well as persons who are in vulnerable situations, including systemic racism in the law enforcement and criminal justice systems, underscoring the importance of ensuring that such acts are not treated with impunity, </p>
      </container>
      <container name="Reaffirming its commitment" eId="container_19">
        <p xml:space="preserve">	<span class="italic">Reaffirming its commitment</span> to a balanced, integrated, comprehensive, multidisciplinary and scientific evidence-based approach to the world drug problem, based on the principle of common and shared responsibility, and recognizing the importance of appropriately mainstreaming a gender and age perspective into drug-related policies and programmes, as well as the full, equal, meaningful and effective participation of women and youth in their design and implementation, and that appropriate emphasis should be placed on individuals, families, communities and society as a whole, with a particular focus on women, children and youth, with a view to strengthening the prevention of drug abuse, including in education settings, as well as promoting and protecting health, including access to treatment, safety and the well-being of all humanity,</p>
      </container>
      <container name="Expressing deep concern" eId="container_20">
        <p xml:space="preserve">	<span class="italic">Expressing deep concern</span> at the high price paid by society and by individuals and their families as a result of the world drug problem, and paying special tribute to those who have sacrificed their lives, including law enforcement and judicial personnel, and to the healthcare and civil society personnel and volunteers whose work is dedicated to countering and addressing this issue, and recognizing that the world drug problem continues to present challenges to the health, safety, security and well-being of all humanity,</p>
      </container>
      <container name="Noting with deep concern" eId="container_21">
        <p xml:space="preserve">
          <span class="italic">	Noting with deep concern </span>that the availability of internationally controlled drugs for medical and scientific purposes, including for the relief of pain and suffering, remains low to nonâexistent in many countries, in particular in developing countries, and highlighting the need to enhance national efforts and international cooperation at all levels to address that situation by promoting measures to ensure access to and the availability of controlled substances for medical and scientific purposes, including for the relief of pain and suffering, and address existing barriers in this regard, including affordability, within the framework of national legal systems, while simultaneously preventing their diversion, abuse and trafficking, in order to fulfil the aims and objectives of the three international drug control conventions, and also expressing concern about the lack of access to quality, safe, effective and affordable medicines for children in appropriate dosage forms and formulations and the problems associated with ensuring the rational use of childrenâs medicines,</p>
      </container>
      <container name="Reaffirming" eId="container_22">
        <p xml:space="preserve">	<span class="italic">Reaffirming</span> that Indigenous Peoples have the right to their traditional medicines and to maintain their health practices, including the conservation of their vital medicinal plants, animals and minerals, and that they also have the right to access, without any discrimination, to all social and health services and to participate in decision-making processes, in accordance with United Nations Declaration on the Rights of Indigenous Peoples,<authorialNote marker="21" placement="bottom" eId="authorialNote_21"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/61/295">61/295</a>, annex.</p></authorialNote></p>
      </container>
      <container name="Welcoming" eId="container_23">
        <p xml:space="preserve">	<span class="italic">Welcoming</span> continued efforts to enhance coherence within the United Nations system at all levels, and reaffirming the need to continue and strengthen cooperation between the United Nations Office on Drugs and Crime and other United Nations entities, including the World Health Organization and the International Narcotics Control Board, within their respective mandates, in their efforts to support Member States in the implementation of international drug control treaties in accordance with applicable human rights obligations and to promote protection of and respect for human rights, fundamental freedoms and the dignity of all individuals in the context of drug programmes, strategies and policies,</p>
      </container>
      <container name="Expressing its appreciation" eId="container_24">
        <p xml:space="preserve">
          <span class="italic">	Expressing its appreciation</span> for the results already achieved by the initiatives at the bilateral, regional and international levels, recognizing that the world drug problem remains a common and shared responsibility that should be addressed in a multilateral setting and that further positive results can be achieved with sustained and collective efforts, through international cooperation, to reduce the demand and supply of illicit drugs, recognizing also that the world drug problem continues to present challenges to the health, including mental health, safety and well-being of all humanity, and resolving to reinforce national and international efforts and further increase international cooperation to face those challenges,</p>
      </container>
      <container name="Reaffirming" eId="container_25">
        <p xml:space="preserve">
          <span class="italic">	Reaffirming</span> the crucial role of Member States in developing an effective, comprehensive, balanced and scientific evidence-based approach to addressing and countering the world drug problem, </p>
      </container>
      <container name="Recognizing" eId="container_26">
        <p xml:space="preserve">	<span class="italic">Recognizing</span> that there are persistent, new and evolving challenges that should be addressed in conformity with the three international drug control conventions, which allow for sufficient flexibility for States parties to design and implement national drug policies according to their national contexts and priorities, consistent with the principle of common and shared responsibility and applicable international law, </p>
      </container>
      <container name="Recognizing also" eId="container_27">
        <p xml:space="preserve">
          <span class="italic">	Recognizing also </span>that misperceptions of drug-related risks, along with other behavioural and socioeconomic factors, in societies can lead to increased or more harmful illicit drug use and require more scientific evidence-based evaluation and further systematic and sustainable preventive approaches to protect people, in particular children and young people, from illicit drug use,</p>
      </container>
      <container name="Reaffirming" eId="container_28">
        <p xml:space="preserve">
          <span class="italic">	Reaffirming </span>the need for close cooperation and coordination among domestic authorities at all levels to address the key causes and consequences of the world drug problem, including those in the health, education, social, human rights, economic, justice, public security and law enforcement fields, in line with the principle of common and shared responsibility, and recognizing the value of comprehensive and balanced policy interventions, including those in the field of promotion of sustainable and viable livelihoods,</p>
      </container>
      <container name="Stressing with grave concern" eId="container_29">
        <p xml:space="preserve">	<span class="italic">Stressing with grave concern</span> the international challenge, particularly to public health, welfare and security, including law enforcement, posed by the illicit manufacture of and trafficking in synthetic drugs and the trafficking and diversion of precursor chemicals, as well as the distribution, consumption and use of synthetic drugs for nonâmedical and nonâscientific purposes, while also stressing with grave concern the increase in the number of overdose deaths associated with the use of synthetic drugs, and the urgent need to raise awareness of and improve access to the prevention and treatment of drug abuse and drug overdose,</p>
      </container>
      <container name="Reaffirming" eId="container_30">
        <p xml:space="preserve">	<span class="italic">Reaffirming </span>that reducing drug abuse requires efforts to reduce demand, which must be demonstrated by sustained widespread demand reduction initiatives that are age- and gender-responsive and integrate a comprehensive, balanced and scientific evidence-based public health approach spanning the spectrum of prevention, education, early detection and intervention, treatment, care and related support services, recovery support and the rehabilitation and social reintegration of drug users, in full compliance with the three international drug control conventions,</p>
      </container>
      <container name="Noting with grave concern" eId="container_31">
        <p xml:space="preserve">
          <span class="italic">	Noting with grave concern </span>the increasing sophistication of the transnational criminal groups engaged in the illicit manufacture and distribution of amphetamine-type stimulants worldwide, as well as the proliferation and diversion of chemical precursors used in the illicit manufacture of narcotic drugs and psychotropic substances, and deeply concerned that new psychoactive substances continue to be a challenge, including the increased abuse of certain drugs and the proliferation of new substances worldwide, which are a threat to public health and are not controlled under the three international drug control conventions,</p>
      </container>
      <container name="Deeply concerned" eId="container_32">
        <p xml:space="preserve">
          <span class="italic">	Deeply concerned </span>that drug traffickers are heavily arming themselves with illicitly trafficked firearms, exposing people, including law enforcement personnel, to significant levels of violence and harm, as outlined in the joint issue paper of the United Nations Office on Drugs and Crime and the Flemish Peace Institute, entitled <span class="italic">Firearms and Drugs: Partners in Transnational Crime</span>, and in this regard recalling Commission on Narcotic Drugs resolution 65/2 of 18Â March 2022,<authorialNote marker="22" placement="bottom" eId="authorialNote_22"><p xml:space="preserve">		See <span class="italic">Official Records of the Economic and Social Council, 2022, Supplement No. 8</span> (<a href="https://undocs.org/en/E/2022/28">E/2022/28</a>), chap. I, sect. B.</p></authorialNote> and underlining the importance of strengthening international cooperation to address in an integrated manner the global challenge posed by the multifaceted links between illicit drug trafficking and the illicit trafficking in and diversion of firearms,</p>
      </container>
      <container name="Welcoming" eId="container_33">
        <p xml:space="preserve">	<span class="italic">Welcoming</span> the progress made in strengthening and expanding existing cooperation on the public health-related aspects of the world drug problem, including progress related to minimizing its adverse public health and social consequences, and reaffirming the need to take into account both the public health and the criminal justice dimensions of the world drug problem, in accordance with the outcome document of the thirtieth special session of the General Assembly, including by intensifying efforts to support Member States, upon request, in addressing and countering the world drug problem in accordance with a comprehensive, integrated and balanced approach,</p>
      </container>
      <container name="Recognizing" eId="container_34">
        <p xml:space="preserve">	<span class="italic">Recognizing</span> the role of promoting healthy lifestyles, health and well-being and health-oriented responses as part of a comprehensive and multifaceted approach in the prevention of the nonâmedical and nonâscientific use of drugs, and acknowledging the necessity of addressing vulnerabilities and fostering resilience among individuals, families, communities and society as a whole to complement other preventive measures, while also emphasizing the significance of evidence-based strategies and interventions as means to empower individuals with knowledge, skills and resilience,</p>
      </container>
      <container name="Reaffirming" eId="container_35">
        <p xml:space="preserve">
          <span class="italic">	Reaffirming </span>that the right to enjoy the highest attainable standard of physical and mental health applies equally to drug users, their children and other family members, regardless of whether they are imprisoned, detained or incarcerated,</p>
      </container>
      <container name="Mindful" eId="container_36">
        <p xml:space="preserve">	<span class="italic">Mindful </span>of the importance of encouraging the voluntary engagement and participation of individuals with drug use disorders in treatment programmes, with informed consent, where consistent with national legislation, and developing and implementing scientific evidence-based outreach programmes and campaigns, involving affected populations, including those in long-term recovery, where appropriate, to promote healthy lifestyles and reduce the adverse health and social consequences of the world drug problem, prevent social marginalization and promote nonâstigmatizing attitudes, as well as of implementing effective outreach to engage and maintain the engagement of people who are in treatment, care or sustained recovery programmes and taking measures to facilitate access to such programmes and related support services, including treatment for comorbidities, and to expand capacity, </p>
      </container>
      <container name="Recalling" eId="container_37">
        <p xml:space="preserve">
          <span class="italic">	Recalling </span>the Political Declaration on HIV and AIDS: Ending Inequalities and Getting on Track to End AIDS by 2030, adopted by the General Assembly on 8Â June 2021,<authorialNote marker="23" placement="bottom" eId="authorialNote_23"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/75/284">75/284</a>, annex.</p></authorialNote></p>
      </container>
      <container name="Acknowledging" eId="container_38">
        <p xml:space="preserve">
          <span class="italic">	Acknowledging </span>the continuously changing environment and the necessity for more proactive, scientific evidence-based, comprehensive and balanced approaches to joint efforts, to ensure that strategies and actions remain agile, effectively responding to new developments and persistent challenges related to illicit cultivation, production, manufacturing, trafficking, distribution and consumption patterns and trends, including the increasing sophistication of methods, routes and techniques of drug trafficking employed by drug traffickers and transnational criminal organizations, increased maritime trafficking, and online sales of drugs through both the darknet and the surface web,</p>
      </container>
      <container name="Recognizing" eId="container_39">
        <p xml:space="preserve">
          <span class="italic">	Recognizing</span> the importance of benefiting from technological innovation and know-how to address persistent, new and emerging trends and challenges, and acknowledging the need for increased international cooperation aimed at addressing and overcoming effectively challenges, obstacles and impediments at all levels to leverage these advancements for joint efforts, as well as the importance of addressing existing technological gaps and the need to strengthen the capabilities of Member States, especially developing countries, through specialized, targeted, effective and sustainable technical assistance to Member States, upon their request,</p>
      </container>
      <container name="Reaffirming" eId="container_40">
        <p xml:space="preserve">	<span class="italic">Reaffirming</span> that alternative development is an important, lawful, viable and sustainable alternative to the illicit cultivation of drug crops and an effective measure to counter the world drug problem and other drug-related crime challenges, and reaffirming also its commitment to addressing drug-related socioeconomic issues related to the illicit cultivation, manufacture, distribution, and production of and trafficking in drugs, through the implementation of long-term, comprehensive, sustainable, development-oriented, balanced and scientific evidence-based drug control policies and programmes, including alternative development and, as appropriate, preventive alternative development programmes, which are part of sustainable crop control strategies,</p>
      </container>
      <container name="Reaffirming also" eId="container_41">
        <p xml:space="preserve">
          <span class="italic">	Reaffirming also</span> its commitment to continue to mobilize resources, including for the provision of technical assistance and capacity-building, at all levels, to ensure that all Member States can effectively address and counter the world drug problem, and calling for the enhancement of assistance to developing countries, upon request, in effectively implementing the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem and the operational recommendations of the outcome document of the thirtieth special session of the General Assembly,</p>
      </container>
      <container name="Expressing concern" eId="container_42">
        <p xml:space="preserve">
          <span class="italic">	Expressing concern </span>that aspects of the world drug problem associated with illicit drug-related activities can cause serious harm to the environment and local communities, including food insecurity, deforestation, soil erosion and degradation, the loss of endemic species, contamination of the soil, groundwater and waterways, and the release of greenhouse gases, and acknowledging the need to address these impacts and their root causes, in a sustainable manner,</p>
      </container>
      <container name="Recognizing" eId="container_43">
        <p xml:space="preserve">
          <span class="italic">	Recognizing </span>the indispensable role of quality, timely, relevant, disaggregated, including geographically disaggregated, and reliable data in driving scientific evidence-based policies to better understand persistent, new and emerging trends, patterns and dynamics, while committing to promoting effective and sustainable capacity-building to strengthen national data collection, analysis and sharing,</p>
      </container>
      <container name="Recalling" eId="container_44">
        <p xml:space="preserve">
          <span class="italic">	Recalling </span>the commitment of Member States in the 2019 Ministerial Declaration to review in the Commission on Narcotic Drugs in 2029 the progress in implementing all international drug policy commitments, </p>
      </container>
    </preamble>
    <mainBody>
      <paragraph eId="para_45" class="SingleTxt">
        <num>1.</num>
        <content eId="para_45__content">
          <p xml:space="preserve">	<span class="italic">Reaffirms</span> the determination of Member States to address and counter the world drug problem, while also recognizing the need to address its key causes and consequences, including those in the law enforcement, health, justice, social, public security, human rights and economic fields, in line with the principle of common and shared responsibility, further reaffirms the determination of Member States to address public health, safety and social problems resulting from drug abuse, and recognizes the value of comprehensive and balanced policy interventions, including those in the field of the promotion of sustainable and viable livelihoods;</p>
        </content>
      </paragraph>
      <paragraph eId="para_46" class="SingleTxt">
        <num>2.</num>
        <content eId="para_46__content">
          <p xml:space="preserve">	<span class="italic">Reaffirms its commitment</span> to respecting, protecting and promoting all human rights, fundamental freedoms and the inherent dignity of all individuals and the rule of law in the development and implementation of drug policies;</p>
        </content>
      </paragraph>
      <paragraph eId="para_48" class="SingleTxt">
        <num>3.</num>
        <content eId="para_48__content">
          <p xml:space="preserve">	<span class="italic">Reiterates its commitment</span> to promoting the health, welfare and well-being of all individuals, families, communities and society as a whole and to facilitating healthy lifestyles through effective, comprehensive, scientific evidence-based demand reduction initiatives at all levels, covering, in accordance with national legislation and the three international drug control conventions, prevention, early intervention, treatment, care, recovery, rehabilitation and social reintegration measures, as well as initiatives and measures aimed at minimizing the adverse public health and social consequences of drug abuse;</p>
        </content>
      </paragraph>
      <paragraph eId="para_51" class="SingleTxt">
        <num>4.</num>
        <content eId="para_51__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to promote bilateral, regional and international cooperation with and technical assistance to the States most affected by illicit crop cultivation and the illicit production, manufacture, transit, trafficking, distribution and use of narcotic drugs and psychotropic substances, including synthetic drugs, in developing and implementing comprehensive and integrated policies, including through intelligence-sharing and cross-border cooperation, and by reinforcing national programmes aimed at education, prevention, early intervention, treatment, care, rehabilitation and social reintegration;</p>
        </content>
      </paragraph>
      <paragraph eId="para_55" class="SingleTxt">
        <num>5.</num>
        <content eId="para_55__content">
          <p xml:space="preserve">	<span class="italic">Welcomes</span> the ongoing efforts to strengthen cooperation in addressing and countering the world drug problem and to ensure that regional and subregional organizations and transregional initiatives consistently undertake comprehensive, balanced and scientific evidence-based strategies and policies; </p>
        </content>
      </paragraph>
      <paragraph eId="para_60" class="SingleTxt">
        <num>6.</num>
        <content eId="para_60__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to engage in effective cooperation and practical action, including North-South, South-South and triangular cooperation, in cooperation with the international development community and other key stakeholders, aimed at addressing and countering the world drug problem on the basis of the principle of common and shared responsibility;</p>
        </content>
      </paragraph>
      <paragraph eId="para_66" class="SingleTxt">
        <num>7.</num>
        <content eId="para_66__content">
          <p xml:space="preserve">	<span class="italic">Also calls upon </span>Member States to strengthen regional, subregional and international cooperation in criminal matters, as appropriate, including judicial cooperation in the areas of, inter alia, extradition, mutual legal assistance and transfer of proceedings, in accordance with the three international drug control conventions and other international legal instruments and national legislation, and to strive to provide appropriate resources to national competent authorities, including through the provision of targeted technical assistance to requesting countries;</p>
        </content>
      </paragraph>
      <paragraph eId="para_73" class="SingleTxt">
        <num>8.</num>
        <content eId="para_73__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to promote prevention, as part of a comprehensive and balanced strategy for drug demand reduction and treatment of drug use disorders, using scientific evidence-based practices that reflect respect for human rights and dignity, including the right to enjoy the highest attainable standard of physical and mental health and well-being, including mental health and psychosocial support services, promoting nonâstigmatizing attitudes in the development and implementation of scientific evidence-based policies, and in this regard takes note of the second updated edition of the International Standards on Drug Use Prevention and the International Standards for the Treatment of Drug Use Disorders, developed by the United Nations Office on Drugs and Crime in collaboration with the World Health Organization;</p>
        </content>
      </paragraph>
      <paragraph eId="para_81" class="SingleTxt">
        <num>9.</num>
        <content eId="para_81__content">
          <p xml:space="preserve">	<span class="italic">Recognizes </span>drug dependence as a complex, multifactorial health disorder characterized by a chronic and relapsing nature, with social causes and consequences, that can be prevented and treated through, inter alia, effective scientific evidence-based drug treatment, care and rehabilitation programmes, including community-based programmes, and also recognizes the need to strengthen capacity for aftercare and the rehabilitation, recovery and social reintegration of individuals with substance use disorders, including through mental health and psychosocial support services and, as appropriate, through assistance for effective reintegration into the labour market and other support services;</p>
        </content>
      </paragraph>
      <paragraph eId="para_90" class="SingleTxt">
        <num>10.</num>
        <content eId="para_90__content">
          <p xml:space="preserve">	<span class="italic">Encourages </span>Member States to develop quality assurance mechanisms for drug prevention, treatment, including for comorbidities, sustained recovery and related support services that reduce the adverse health and social consequences of drug abuse with a view to ensuring continuous improvement, through, inter alia, effective supervision of drug treatment and rehabilitation facilities by competent domestic authorities, including to prevent any possible acts of cruel, inhuman or degrading treatment or punishment, in accordance with national legislation and applicable international law; </p>
        </content>
      </paragraph>
      <paragraph eId="para_100" class="SingleTxt">
        <num>11.</num>
        <content eId="para_100__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to promote and implement scientific evidence-based approaches to prevention, treatment, care and recovery, as well as other public health interventions to address the harm associated with illicit drug use as part of comprehensive, systematic and sustainable demand reduction initiatives;</p>
        </content>
      </paragraph>
      <paragraph eId="para_111" class="SingleTxt">
        <num>12.</num>
        <content eId="para_111__content">
          <p xml:space="preserve">	<span class="italic">Encourages </span>Member States to promote the inclusion in national drug policies, in accordance with national legislation and as appropriate, of elements for the prevention and treatment of drug overdose, in particular opioid overdose, including the use of opioid receptor antagonists, such as naloxone, to reduce drug-related mortality;</p>
        </content>
      </paragraph>
      <paragraph eId="para_123" class="SingleTxt">
        <num>13.</num>
        <content eId="para_123__content">
          <p xml:space="preserve">	<span class="italic">Urges</span> Member States to increase the availability, coverage and quality of scientific evidence-based prevention measures and tools, especially life skills programmes with demonstrated effectiveness, that target relevant age and risk groups in multiple settings, including in educational institutions, in both the public and private sectors, reaching youth in school as well as out of school, among others, including by providing children and youth with evidence-based information on drug abuse and its harmful effects and consequences as well as through drug use prevention programmes and public awareness-raising campaigns, including by using the Internet, social media and other online platforms, to develop and implement prevention curricula and early intervention programmes for use in the education system at all levels, as well as in vocational training, including in the workplace, and to enhance the capacity of teachers and other relevant professionals, as well as that of parents and guardians, to provide or recommend counselling, prevention and healthcare services, and opportunities to choose healthy lifestyles, and to promote safe and drug-free environments;</p>
        </content>
      </paragraph>
      <paragraph eId="para_136" class="SingleTxt">
        <num>14.</num>
        <content eId="para_136__content">
          <p xml:space="preserve">	<span class="italic">Invites</span> Member States to consider enhancing cooperation among public health, education and law enforcement authorities when developing and implementing scientific evidence-based drug use prevention initiatives;</p>
        </content>
      </paragraph>
      <paragraph eId="para_150" class="SingleTxt">
        <num>15.</num>
        <content eId="para_150__content">
          <p xml:space="preserve">	<span class="italic">Acknowledges </span>the important advances made in prevention science, establishing prevention as one of the main components of comprehensive, scientific evidence-based demand-reduction initiatives to address the nonâmedical and nonâscientific use of controlled drugs, and also acknowledges that effective early prevention strategies and measures focused on addressing, inter alia, adverse childhood experiences as well as individual and environmental, including social, risk and protective, factors, contribute significantly to the positive engagement of children, youth and adults with their families and in educational settings, workplaces and communities;</p>
        </content>
      </paragraph>
      <paragraph eId="para_165" class="SingleTxt">
        <num>16.</num>
        <content eId="para_165__content">
          <p xml:space="preserve">	<span class="italic">Reiterates </span>the strong commitment of Member States to improve access to controlled substances for medical and scientific purposes by appropriately addressing existing barriers in this regard, while concurrently preventing the diversion and abuse of and trafficking in such substances, and to strengthen, as appropriate, the proper functioning of national drug control systems and domestic assessment mechanisms and programmes, with a view to promoting the safety, health and welfare of humankind, in cooperation with the International Narcotics Control Board, the United Nations Office on Drugs and Crime, the World Health Organization and other relevant United Nations system agencies, to identify, analyse and remove impediments to the access to and availability of controlled substances for medical and scientific purposes, including for the relief of pain and suffering, and address existing barriers in this regard, including affordability, within appropriate control mechanisms, as required by the three international drug control conventions and, for that purpose, to consider the provision of technical and financial assistance, upon request, to developing countries;</p>
        </content>
      </paragraph>
      <paragraph eId="para_181" class="SingleTxt">
        <num>17.</num>
        <content eId="para_181__content">
          <p xml:space="preserve">	<span class="italic">Urges</span> Member States to enact comprehensive measures aimed at stemming the abuse, diversion and misuse of prescription drugs, in particular through the establishment of awareness-raising initiatives targeting the general public and healthcare providers, and in this regard encourages Member States to establish and strengthen partnerships and information exchange with industries, in particular with chemical and pharmaceutical industries and other relevant private sector entities, bearing in mind the important role that these industries can play in addressing and countering the world drug problem;</p>
        </content>
      </paragraph>
      <paragraph eId="para_198" class="SingleTxt">
        <num>18.</num>
        <content eId="para_198__content">
          <p xml:space="preserve">	<span class="italic">Also urges</span> Member States to develop and carry out comprehensive, balanced, scientific evidence-based and forward-looking strategies at all applicable levels to effectively address and counter challenges posed by the illicit manufacture of and trafficking in synthetic drugs, as well as their distribution, consumption and use for nonâmedical and nonâscientific purposes, including interventions related to prevention, treatment and recovery support, measures aimed at minimizing the adverse public health and social consequences of synthetic drug use, particularly overdose, including by raising awareness of and improving access to the prevention and treatment of drug overdose, as well as preventing and countering drug-related crime and violence and the trafficking and diversion of synthetic drugs, their precursor chemicals, including nonâscheduled and designer precursor chemicals, and equipment used in the illicit manufacture of synthetic drugs;</p>
        </content>
      </paragraph>
      <paragraph eId="para_216" class="SingleTxt">
        <num>19.</num>
        <content eId="para_216__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to strengthen national and international action to address the emerging challenge of new psychoactive substances, including their adverse health consequences, and the evolving threat of amphetamine-type stimulants, including methamphetamine, underscores the importance of building the capacity of law enforcement agencies to detect and identify these substances, enhancing information-sharing, cross-border cooperation and early warning networks to prevent their abuse and diversion, developing appropriate national legislative, prevention and treatment models and supporting scientific evidence-based review and scheduling of the most prevalent, persistent and harmful substances, and notes the importance of preventing the diversion and the misuse of pharmaceuticals containing narcotic drugs and psychotropic substances and precursors, while ensuring their access and availability for medical and scientific purposes, including for the relief of pain and suffering, and addressing existing barriers in this regard, including affordability;</p>
        </content>
      </paragraph>
      <paragraph eId="para_235" class="SingleTxt">
        <num>20.</num>
        <content eId="para_235__content">
          <p xml:space="preserve">	<span class="italic">Urges</span> Member States to reduce the adverse health and social consequences of the world drug problem through a comprehensive approach, including by utilizing existing United Nations Office on Drugs and Crime technical assistance tools, and ensuring that scientific evidence-based treatment is available;</p>
        </content>
      </paragraph>
      <paragraph eId="para_255" class="SingleTxt">
        <num>21.</num>
        <content eId="para_255__content">
          <p xml:space="preserve">
            <span class="italic">	Urges</span> Member States and other donors to continue to provide bilateral and other funding for the world drug problem response, including in particular the HIV/AIDS response, including to the Joint United Nations Programme on HIV/AIDS, and to strive to ensure that such funding contributes to addressing the growing HIV/AIDS epidemic among people who inject drugs, and HIV/AIDS in prison settings, in the spirit of the pledge made in the 2030 Agenda for Sustainable Development to leave no one behind;</p>
        </content>
      </paragraph>
      <paragraph eId="para_276" class="SingleTxt">
        <num>22.</num>
        <content eId="para_276__content">
          <p xml:space="preserve">	<span class="italic">Invites</span> relevant national authorities to consider, in accordance with their domestic law and the three international drug control conventions, including in national prevention, treatment, care, recovery, rehabilitation and social reintegration measures and programmes, in the context of comprehensive and balanced drug demand reduction efforts, effective scientific evidence-based measures aimed at minimizing the adverse public health and social consequences of drug abuse, including appropriate medication-assisted therapy programmes, injecting equipment programmes as well as antiretroviral therapy and other relevant interventions that prevent the transmission of HIV, viral hepatitis and other blood-borne diseases associated with drug use, and to consider ensuring access to such interventions, including in treatment and outreach services, prisons and other custodial settings, and promoting in that regard the use, as appropriate, of the technical guide for countries to set targets for universal access to HIV prevention, treatment and care for people who inject drugs, issued by the World Health Organization, the United Nations Office on Drugs and Crime and the Joint United Nations Programme on HIV/AIDS;</p>
        </content>
      </paragraph>
      <paragraph eId="para_298" class="SingleTxt">
        <num>23.</num>
        <content eId="para_298__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to consider alternative, nonâcustodial measures for persons accused of minor, nonâviolent drug-related offences, to promote, consistent with the three international drug control conventions and domestic law, and in accordance with national, constitutional, legal and administrative systems, alternative or additional measures with regard to conviction or punishment in cases of an appropriate nature, and to ensure that law enforcement drug control efforts are both consistent with Statesâ commitments to effectively addressing and countering the world drug problem as well as their human rights obligations;</p>
        </content>
      </paragraph>
      <paragraph eId="para_321" class="SingleTxt">
        <num>24.</num>
        <content eId="para_321__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to promote and implement effective criminal justice responses to drug-related crimes to bring perpetrators to justice that ensure legal guarantees and due process safeguards pertaining to criminal justice proceedings, including practical measures to uphold the prohibition of arbitrary arrest and detention and of torture and other cruel, inhuman or degrading treatment or punishment and to eliminate impunity, in accordance with relevant and applicable international law and taking into account United Nations standards and norms on crime prevention and criminal justice, and ensure timely access to legal aid and the right to a fair trial;</p>
        </content>
      </paragraph>
      <paragraph eId="para_345" class="SingleTxt">
        <num>25.</num>
        <content eId="para_345__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to promote proportionate national sentencing policies, practices and guidelines for drug-related offences, whereby the severity of penalties is proportionate to the gravity of offences and both mitigating and aggravating factors are taken into account, including the circumstances enumerated in article 3 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 and other relevant and applicable international law, and in accordance with national legislation;</p>
        </content>
      </paragraph>
      <paragraph eId="para_370" class="SingleTxt">
        <num>26.</num>
        <content eId="para_370__content">
          <p xml:space="preserve">	<span class="italic">Reiterates its commitment </span>to protect the safety and assure the security of individuals, societies and communities by intensifying efforts to prevent and counter the illicit cultivation, production and manufacture of and trafficking in narcotic drugs and psychotropic substances, as well as drug-related crime and violence, through, inter alia, more effective drug-related crime prevention and law enforcement measures, as well as by addressing links with other forms of organized crime, including firearms trafficking, money-laundering, corruption and other criminal activities, mindful of their social and economic causes and consequences, including environmental consequences; </p>
        </content>
      </paragraph>
      <paragraph eId="para_396" class="SingleTxt">
        <num>27.</num>
        <content eId="para_396__content">
          <p xml:space="preserve">	<span class="italic">Calls for</span> strengthening common efforts of Member States to promote the use of new technologies and means to counter illicit trafficking of narcotic drugs and psychotropic substances and their precursor chemicals, including through the darknet and the surface web and social networks, as well as to prevent the use of electronic payment systems and virtual assets, including those provided by virtual asset service providers, and nonâcash assets, for these purposes, through continued development and implementation of measures aimed at mitigating risks associated with these assets and preventing their misuse and abuse for illicit drug-related purposes;</p>
        </content>
      </paragraph>
      <paragraph eId="para_423" class="SingleTxt">
        <num>28.</num>
        <content eId="para_423__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to enhance national, regional, subregional, interregional and international capacity, and utilize existing and relevant regional and, as appropriate, subregional and international networks for the exchange of operational information to respond to the serious challenges posed by the increasing links between drug trafficking, corruption and other forms of organized crime, including trafficking in persons, illicit trafficking in firearms, cybercrime and money-laundering, and, in some cases, terrorism, including money-laundering in connection with the financing of terrorism, by using an integrated and multidisciplinary approach, such as through promoting and supporting reliable data collection, research and, as appropriate, intelligence- and analysis-sharing to ensure effective policymaking and interventions, by using, inter alia, existing United Nations Office on Drugs and Crime and International Criminal Police Organization (INTERPOL) technical assistance tools;</p>
        </content>
      </paragraph>
      <paragraph eId="para_451" class="SingleTxt">
        <num>29.</num>
        <content eId="para_451__content">
          <p xml:space="preserve">	<span class="italic">Also calls upon</span> Member States to promote and strengthen the exchange of information and, as appropriate, drug-related criminal intelligence among law enforcement and border control agencies, including through the United Nations Office on Drugs and Crime multilateral portals and regional information centres and networks, and to promote joint investigations and coordinate operations, in conformity with national legislation, and training programmes at all levels, in order to identify, disrupt and dismantle organized criminal groups operating transnationally that are involved in any activities related to the illicit production of and trafficking in narcotic drugs and psychotropic substances and the diversion of their precursors and related money-laundering;</p>
        </content>
      </paragraph>
      <paragraph eId="para_480" class="SingleTxt">
        <num>30.</num>
        <content eId="para_480__content">
          <p xml:space="preserve">	<span class="italic">Further calls upon</span> Member States to adopt and strengthen coordinated border management strategies, if needed, to prevent, monitor and counter the illicit production, manufacture and trafficking of narcotic drugs and psychotropic substances, including when associated with other forms of transnational organized crime, such as trafficking in firearms, illicit financial flows, smuggling of goods and of bulk cash, and money-laundering, and also calls upon Member States to provide technical assistance, upon request, including where appropriate the provision of equipment and technology, along with necessary training and maintenance support, to increase the capacity of border and law enforcement agencies, in particular for developing countries;</p>
        </content>
      </paragraph>
      <paragraph eId="para_510" class="SingleTxt">
        <num>31.</num>
        <content eId="para_510__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to enhance national, regional, subregional, interregional and international capacity, and utilize existing and relevant regional and, as appropriate, subregional and international networks for the exchange of operational information to prevent and counter money-laundering and illicit financial flows stemming from drug trafficking and related crimes, including terrorist financing, and, as appropriate, through the detection, investigation and prosecution of such activities, with the view to effectively addressing safe havens, and to identify and mitigate money-laundering linked to new technologies, as well as emerging money-laundering methods and techniques, by using, inter alia, existing United Nations Office on Drugs and Crime technical assistance tools;</p>
        </content>
      </paragraph>
      <paragraph eId="para_541" class="SingleTxt">
        <num>32.</num>
        <content eId="para_541__content">
          <p xml:space="preserve">	<span class="italic">Recognizes </span>that transit States continue to face multifaceted challenges, and reaffirms the continuing need for cooperation and support, including the provision of technical assistance, to, inter alia, enhance their capacities to effectively address and counter the world drug problem, in conformity with the 1988 Convention;</p>
        </content>
      </paragraph>
      <paragraph eId="para_573" class="SingleTxt">
        <num>33.</num>
        <content eId="para_573__content">
          <p xml:space="preserve">	<span class="italic">Reiterates its commitment </span>to strengthen specialized, targeted, effective and sustainable technical assistance, including, where appropriate, adequate financial assistance, training, capacity-building, equipment and technological know-how, to requesting countries, including transit countries, through and in cooperation with the United Nations Office on Drugs and Crime, as well as the World Health Organization and other relevant United Nations entities and international and regional organizations, within their respective mandates, so as to help Member States to effectively address the health, socioeconomic, human rights, justice and law enforcement aspects of the world drug problem;</p>
        </content>
      </paragraph>
      <paragraph eId="para_606" class="SingleTxt">
        <num>34.</num>
        <content eId="para_606__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to ensure that measures to prevent the illicit cultivation of and to eradicate plants containing narcotic and psychotropic substances respect fundamental human rights, take due account of traditional licit uses, where there is historical evidence of such use, and of the protection of the environment, in accordance with the three international drug control conventions, and also take into account, as appropriate and in accordance with domestic law, the United Nations Declaration on the Rights of Indigenous Peoples; </p>
        </content>
      </paragraph>
      <paragraph eId="para_640" class="SingleTxt">
        <num>35.</num>
        <content eId="para_640__content">
          <p xml:space="preserve">	<span class="italic">Also encourages</span> Member States to improve the assessment of the impact of demand and supply reduction strategies, including the impact of alternative development programmes and preventive alternative development programmes, as appropriate, with a view to increasing the effectiveness of such programmes, including through the use of relevant human development indicators, criteria related to environmental sustainability and other measurements in line with the Sustainable Development Goals, and further encourages Member States to examine and address the harmful impacts of illicit drug-related activities on the environment, which lead to illegal deforestation, the pollution of soil and water, and negative consequences on food safety, and to seize the opportunities offered by alternative development with regard to the conservation and sustainable use of the environment and the protection of biodiversity, as well as to develop other policies and strategies to properly address those impacts;</p>
        </content>
      </paragraph>
      <paragraph eId="para_675" class="SingleTxt">
        <num>36.</num>
        <content eId="para_675__content">
          <p xml:space="preserve">	<span class="italic">Recognizes</span> the need for strengthening sustainable crop control strategies that may include, inter alia, alternative development, eradication and law enforcement measures, and in this regard encourages Member States to consider development-oriented interventions to address the illicit cultivation of drug crops and other illicit drug-related activities, while ensuring that both men and women benefit equally from them, including through job opportunities, improved infrastructure and basic public services and, as appropriate, access and legal titles to land for farmers and local communities; </p>
        </content>
      </paragraph>
      <paragraph eId="para_711" class="SingleTxt">
        <num>37.</num>
        <content eId="para_711__content">
          <p xml:space="preserve">	<span class="italic">Reiterates its commitment </span>to strengthen subregional, regional and international cooperation, in accordance with the principle of common and shared responsibility, to support comprehensive and sustainable alternative development programmes, including, as appropriate, preventive alternative development, in close collaboration with all relevant stakeholders at the local, national and international levels, and to develop and share best practices towards implementing the United Nations Guiding Principles on Alternative Development,<authorialNote marker="24" placement="bottom" eId="authorialNote_24"><p xml:space="preserve">		Resolution <a href="https://undocs.org/en/A/RES/68/196">68/196</a>, annex.</p></authorialNote> taking into account all the lessons learned and good practices, in particular by countries with extensive expertise in alternative development, and in this regard recalls its resolution <a href="https://undocs.org/en/A/RES/72/197">72/197</a> of 19Â December 2017, as well as Commission on Narcotic Drugs resolution 67/3 of 22Â March 2024;<authorialNote marker="25" placement="bottom" eId="authorialNote_25"><p xml:space="preserve">		See <span class="italic">Official Records of the Economic and Social Council, 2024, Supplement No. 8</span> (<a href="https://undocs.org/en/E/2024/28">E/2024/28</a>), chap. I, sect. B. </p></authorialNote></p>
        </content>
      </paragraph>
      <paragraph eId="para_748" class="SingleTxt">
        <num>38.</num>
        <content eId="para_748__content">
          <p xml:space="preserve">	<span class="italic">Urges</span> relevant international financial institutions, United Nations entities, nonâgovernmental organizations and the private sector, as appropriate, to consider increasing their support, including through long-term and flexible funding, for the implementation of comprehensive, balanced and scientific evidence-based development-oriented drug control programmes and viable economic alternatives for the promotion of inclusive economic growth and support for initiatives that contribute to poverty eradication, inter alia, alternative development, including, as appropriate, preventive alternative development programmes, based on identified needs and national priorities, for areas and populations affected by or vulnerable to the illicit cultivation of drug crops, and encourages Member States to develop measures for rural development, improving infrastructure and social inclusion and protection, as well as for addressing the consequences of illicit crop cultivation and the manufacture and production of narcotic drugs and psychotropic substances on the environment, with the incorporation and participation of local communities; </p>
        </content>
      </paragraph>
      <paragraph eId="para_786" class="SingleTxt">
        <num>39.</num>
        <content eId="para_786__content">
          <p xml:space="preserve">	<span class="italic">Calls upon </span>Member States to ensure the participation of local communities, farmers, women, Indigenous Peoples and persons in vulnerable situations in the design and implementation of alternative development programmes and to secure alternative livelihoods, preferably before removing existing livelihoods earned from the cultivation of illicit crops;</p>
        </content>
      </paragraph>
      <paragraph eId="para_825" class="SingleTxt">
        <num>40.</num>
        <content eId="para_825__content">
          <p xml:space="preserve">	<span class="italic">Also calls upon </span>Member States to mainstream a gender perspective into and ensure the full, equal, meaningful and effective participation and leadership of women in all stages of the development, implementation, monitoring and evaluation of drug policies and programmes, including drug prevention, treatment, sustained recovery, reintegration and related support services, to develop and disseminate gender-sensitive and age-appropriate measures that take into account the specific needs and circumstances faced by women and girls with regard to the world drug problem, in line with the Beijing Declaration and Platform for Action,<authorialNote marker="26" placement="bottom" eId="authorialNote_26"><p xml:space="preserve">		<span class="italic">Report of the Fourth World Conference on Women, Beijing, 4â15 September 1995</span> (United Nations publication, Sales No. E.96.IV.13), chap. I, resolution 1, annexes I and II.</p></authorialNote> and the outcomes of its review conferences, and, as States parties, implement the Convention on the Elimination of All Forms of Discrimination against Women,<authorialNote marker="27" placement="bottom" eId="authorialNote_27"><p xml:space="preserve">		United Nations, <span class="italic">Treaty Series</span>, vol. 1249, No. 20378.</p></authorialNote> and bearing in mind the importance of targeted interventions that are based on the collection and analysis of data, including age- and gender-related data, in meeting the specific needs of drug-affected populations and communities;</p>
        </content>
      </paragraph>
      <paragraph eId="para_865" class="SingleTxt">
        <num>41.</num>
        <content eId="para_865__content">
          <p xml:space="preserve">	<span class="italic">Requests</span> the United Nations Office on Drugs and Crime to continue to support Member States, upon request, in mainstreaming a gender perspective into their policies and programmes related to the world drug problem, and invites the United Nations Entity for Gender Equality and the Empowerment of Women (UNâWomen) and other relevant United Nations entities, within their mandates, to cooperate with the Office in this regard; </p>
        </content>
      </paragraph>
      <paragraph eId="para_906" class="SingleTxt">
        <num>42.</num>
        <content eId="para_906__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> the consideration of the specific needs and possible multiple vulnerabilities of women drug offenders when imprisoned, taking into account the United Nations Rules for the Treatment of Women Prisoners and Non-custodial Measures for Women Offenders (the Bangkok Rules);</p>
        </content>
      </paragraph>
      <paragraph eId="para_948" class="SingleTxt">
        <num>43.</num>
        <content eId="para_948__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to adapt their drug policies and to consider, when developing comprehensive, balanced and scientific evidence-based policies to address and counter the world drug problem, measures, programmes and actions that respond to the specific needs of members of society in situations of vulnerability; </p>
        </content>
      </paragraph>
      <paragraph eId="para_991" class="SingleTxt">
        <num>44.</num>
        <content eId="para_991__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to identify and take advantage of opportunities to conduct collaborative research and continuously share the latest scientific research, taking into account the contributions of the national, regional and international scientific community, including academia, on the most effective demand and supply reduction strategies, and to develop improved best practices on interventions to reduce demand for and supply of illicit drugs, in accordance with the three international drug control conventions and drug policy commitments;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1035" class="SingleTxt">
        <num>45.</num>
        <content eId="para_1035__content">
          <p xml:space="preserve">	<span class="italic">Invites</span> Member States to promote and improve the systematic collection of information and gathering of evidence as well as the sharing, at the national and international levels, of reliable and comparable data on drug use and epidemiology, including scientific data on any risks or damage to health and societal consequences that are caused by abusing drugs, including in vaporized form, on the scope and patterns of illicit drug use, and on social, economic and other risk factors, as well as on the links between drug policies and human rights, to promote, as appropriate, through the Commission on Narcotic Drugs and the World Health Assembly, the use of internationally recognized standards, such as the International Standards on Drug Use Prevention, and the exchange of best practices, and to formulate effective drug use prevention strategies and programmes in cooperation with the United Nations Office on Drugs and Crime, the World Health Organization and other relevant United Nations entities;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1080" class="SingleTxt">
        <num>46.</num>
        <content eId="para_1080__content">
          <p xml:space="preserve">	<span class="italic">Also invites</span> Member States to provide the United Nations Office on Drugs and Crime with information on best practices and programmes recently implemented, consistent with the three international drug control conventions, in order to assess recent developments and current and future challenges;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1126" class="SingleTxt">
        <num>47.</num>
        <content eId="para_1126__content">
          <p xml:space="preserve">	<span class="italic">Stresses</span> the need for national statistical capacity-building to support Member States in improving the quality and availability of drug statistics and to respond effectively to data-collection requests from the United Nations Office on Drugs and Crime, invites international and regional organizations, as well as civil society, affected communities and academia, to support Member States in this regard, upon their request, invites Member States to regularly report data and information relating to all aspects of the world drug problem to the Office through the annual report questionnaires, and invites the Commission on Narcotic Drugs, as the central policymaking body of the United Nations system on drug-related matters, to strengthen the capacity of the Office to collect, analyse, use and disseminate accurate, reliable, objective and comparable data and to reflect such information in the <span class="italic">World Drug Report</span>;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1173" class="SingleTxt">
        <num>48.</num>
        <content eId="para_1173__content">
          <p xml:space="preserve">	<span class="italic">Invites</span> Member States to consider the need to review the set of national drug policy metrics and tools for the collection and analysis of accurate, reliable, disaggregated, comprehensive and comparable data to measure the effectiveness of programmes to address all relevant aspects of the world drug problem, including, as appropriate, as related to the 2030 Agenda;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1221" class="SingleTxt">
        <num>49.</num>
        <content eId="para_1221__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> Member States to promote data collection, research and the sharing of information, as well as the exchange of best practices on preventing and countering drug-related crime and on drug supply reduction measures and practices, in order to enhance the effectiveness of criminal justice responses, within the framework of applicable law;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1270" class="SingleTxt">
        <num>50.</num>
        <content eId="para_1270__content">
          <p xml:space="preserve">	<span class="italic">Requests</span> the United Nations Office on Drugs and Crime to continue to assist Member States, upon request, with data collection, research and, as appropriate, intelligence- and analysis-sharing to disclose the extent of the links between illicit drug trafficking and other transnational criminal activities, in particular firearms trafficking, and to continue its already existing research on these links, subject to the availability of extrabudgetary resources;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1320" class="SingleTxt">
        <num>51.</num>
        <content eId="para_1320__content">
          <p xml:space="preserve">	<span class="italic">Calls upon</span> Member States to intensify efforts to prevent and counter the illicit cultivation, production and manufacture of and trafficking in narcotic drugs and psychotropic substances, as well as drug-related crime and violence, through, inter alia, more effective drug-related crime prevention and law enforcement measures consistent with national legislation and international law, including applicable human rights obligations, as well as by addressing links with other forms of organized crime, including firearms trafficking, money-laundering, corruption and, in some cases, terrorism, as well as other transnational criminal activities, mindful of their social and economic causes and consequences;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1371" class="SingleTxt">
        <num>52.</num>
        <content eId="para_1371__content">
          <p xml:space="preserve">	<span class="italic">Reaffirms</span> the importance of an integrated approach in drug policies, including by strengthening partnerships between the public health, development, human rights, justice and law enforcement fields, as well as the private sector, in particular chemical and pharmaceutical industries, and by facilitating inter-agency cooperation and communication, where appropriate;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1423" class="SingleTxt">
        <num>53.</num>
        <content eId="para_1423__content">
          <p xml:space="preserve">	<span class="italic">Recognizes</span> that civil society, the scientific community, academia, the private sector and affected communities play a significant role in addressing and countering the world drug problem by analysing drugs issues, in delivering services and in evaluating the human rights impact of drug policies, and encourages, where appropriate, the participation of civil society and affected communities in the design, implementation and provision of relevant scientific evidence in support of the evaluation of drug control policies and programmes; </p>
        </content>
      </paragraph>
      <paragraph eId="para_1476" class="SingleTxt">
        <num>54.</num>
        <content eId="para_1476__content">
          <p xml:space="preserve">	<span class="italic">Reaffirms</span> the importance of the United Nations Office on Drugs and Crime and its field offices in building capacity at the local level in addressing and countering the world drug problem, encourages the Office to maintain an effective level of support for national and regional efforts, requests all Member States to provide the fullest possible financial and political support to the Office by widening its donor base, as appropriate, and increasing voluntary contributions, in particular general-purpose contributions, so as to enable it to continue, expand, improve and strengthen, within its mandates, its operational and technical cooperation activities, and requests the Office to continue to collaborate with relevant intergovernmental, international and regional organizations involved in addressing and countering the world drug problem, as appropriate, in order to share best practices and scientific standards and to maximize the benefits from their unique comparative advantage;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1530" class="SingleTxt">
        <num>55.</num>
        <content eId="para_1530__content">
          <p xml:space="preserve">	<span class="italic">Requests</span> the United Nations Office on Drugs and Crime and the International Narcotics Control Board to continue to strengthen cooperation with the World Health Organization and other competent United Nations entities, within their respective mandates, as part of a comprehensive, integrated, balanced and scientific evidence-based approach to addressing the world drug problem and strengthening health and social welfare measures to do so, including through effective prevention, early intervention, treatment, care, recovery, rehabilitation and social reintegration, in cooperation, as appropriate, with civil society and the scientific community, and to keep the Commission on Narcotic Drugs appropriately updated;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1585" class="SingleTxt">
        <num>56.</num>
        <content eId="para_1585__content">
          <p xml:space="preserve">	<span class="italic">Requests</span> the United Nations Office on Drugs and Crime, in close cooperation with Member States, the International Narcotics Control Board, and pertinent United Nations entities, intergovernmental and regional organizations and the scientific community and civil society, to continue to support Member States, upon request, in strengthening their capacity to develop their reporting mechanisms, including through technical assistance, by identifying gaps in the current drug statistics and by exploring possibilities to strengthen existing data-collection and analysis tools at the national level; and to provide technical assistance to Governments so as to facilitate the implementation of and enable them to fully meet their obligations under the conventions and give adequate follow-up to subsequent resolutions of the Commission on Narcotic Drugs, the Economic and Social Council and the General Assembly; </p>
        </content>
      </paragraph>
      <paragraph eId="para_1641" class="SingleTxt">
        <num>57.</num>
        <content eId="para_1641__content">
          <p xml:space="preserve">	<span class="italic">Urges</span> Member States to continue to actively cooperate with the International Narcotics Control Board in the exercise of its treaty-mandated role, and reiterates the need to ensure that an appropriate level of resources is made available to the Board;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1698" class="SingleTxt">
        <num>58.</num>
        <content eId="para_1698__content">
          <p xml:space="preserve">	<span class="italic">Encourages</span> all relevant United Nations entities, in close cooperation with the United Nations Office on Drugs and Crime, to support Member States in developing and implementing balanced, comprehensive, integrated, multidisciplinary, scientific evidence-based, development-oriented and sustainable responses to the world drug problem, while respecting human rights, within the framework of the three international drug control conventions;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1756" class="SingleTxt">
        <num>59.</num>
        <content eId="para_1756__content">
          <p xml:space="preserve">	<span class="italic">Welcomes</span> the adoption by the Commission on Narcotic Drugs of the new workplan for the thematic discussions to be held from 2024 to 2028, in preparation for the final review of the 2019 Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem in 2029, encourages the Commission to continue to work on and support Member States in their implementation and sharing of scientific and evidence-based best practices in addressing and countering the world drug problem, and invites the Commission to continue to examine how its subsidiary bodies can better contribute to the implementation of, inter alia, the outcome document of the thirtieth special session of the General Assembly and all relevant commitments by ensuring that the Commission is informed of regional and domestic concerns, developments and best practices arising from all relevant stakeholders, including contributions from the scientific community, academia and civil society;</p>
        </content>
      </paragraph>
      <paragraph eId="para_1815" class="SingleTxt">
        <num>60.</num>
        <content eId="para_1815__content">
          <p xml:space="preserve">	<span class="italic">Takes note</span> of the report of the Secretary-General,<authorialNote marker="28" placement="bottom" eId="authorialNote_28"><p xml:space="preserve">		<a href="https://undocs.org/en/A/79/120">A/79/120</a>.</p></authorialNote> and requests that he submit to the General Assembly at its eighty-first session a report on the implementation of the present resolution.</p>
        </content>
      </paragraph>
    </mainBody>
    <conclusions eId="conclusions">
      <p>
        <event refersTo="#adoption">
          <location title="53rd" refersTo="#adoptionMeeting">53rd plenary meeting</location>
          <eol />
          <docDate date="2024-12-17" refersTo="#adoptionDate">17Â December 2024</docDate>
        </event>
      </p>
    </conclusions>
  </statement>
</akomaNtoso>